首页|HPV E6/E7 mRNA检测对HPV16/18 DNA阳性患者的分流价值

HPV E6/E7 mRNA检测对HPV16/18 DNA阳性患者的分流价值

扫码查看
目的 探讨HPV E6/E7 mRNA对HPV16/18 DNA阳性患者的分流价值.方法 收集127例HPV16/18 DNA阳性的核酸样本,行HPV E6/E7 mRNA检测,并结合宫颈液基细胞学(TCT)结果和病理诊断结果进行统计分析.结果 ①HPV E6/E7 mRNA检出型别以单一感染为主,占比81.93%.年龄分布显示呈双峰状.②HPV E6/E7 mRNA总阳性率为65.35%,且随着宫颈病变程度升高,HPV E6/E7 mRNA阳性率升高.且LSIL组与炎症组,HSIL+组与炎症组阳性率比较,差异有统计学意义(P<0.05).③对HPV 16/18 DNA阳性者,用细胞学进一步分流,可以减少65.35%的阴道镜检查,漏诊44.83%的HSIL+;采用HPV E6/E7 mRNA进行分流,可以减少34.65%的阴道镜检查,漏诊10.34%的HSIL+;HPV E6/E7 mRNA分流漏诊率低于TCT分流方法,差异有统计学意义(P<0.05).④HPV16/18 DNA阳性且细胞学检查为≥ASC-US的患者,经HPV E6/E7 mRNA分流,可减少11.36%的阴道镜检查,无漏诊HSIL+.结论 HPV16/18 DNA阳性者进一步用TCT联合HPV E6/E7 mRNA进行同步分流,可以减少阴道镜检查,同时降低≥ASC-US的患者漏诊HSIL+的风险.
Shunt Value of HPV E6/E7 mRNA Detection in HPV16/18 DNA Positive Patients
Objective To investigate the value of HPV E6/E7 mRNA in the shunt of HPV16/18 DNA positive patients.Methods A total of 127 cases of HPV16/18 DNA positive nucleic acid samples were collected,and HPV E6/E7 mRNA was detected.The results were statistically analyzed in combination with the results of thinprepcytologic test(TCT)and pathological diagnosis.Results ①The HPV E6/E7 mRNA was detected by mainly single infection,accounting for 81.93%.The age distribution showed a bimodal shape.②The total positive rate of HPV E6/E7 mRNA was 65.35%.With the increase of cervical lesions,the positive rate of HPV E6/E7 mRNA increased,while the positive rate of LSIL group and inflammation group,HSIL+group and inflammation group was statistically significant(P<0.05).③As the HPV 16/18 DNA positivity triage test,Cytology at the ASC-US+threshold could reduce colposcopy by 65.35%,but missed diagnosis of HSIL+by 44.83%;whereas HPVE6/E7 mRNA could reduce the colposcopy by 34.65%,and missed diagnosis of HSIL+by 10.34%.As a triage test in HPV 16/18 DNA positivity patients,the missed diagnosis rate of HPV E6/E7 mRNA was lower than that of TCT(P<0.05).④As a triage test,in patients with HPV16/18 DNA positive and cytological grades ≥ASC-US,E6/E7 mRNA could reduce the colposcopy by 11.36%and none missed diagnosis of HSIL+.Conclusion TCT combined with HPV E6/E7 mRNA for synchronous shunt in HPV16/18 DNA positive patients can reduce colposcopy and the risk of missed diagnosis of HS1L+in patients with ≥ASC-US.

HPV E6/E7 mRNAHPVTCTHigh-grade squamous intraepithelial lesion

王意、李子珊、雷雯、黄淑君、彭盼

展开 >

广东省妇幼保健院妇女保健科,广东 广州 511400

广东省妇幼保健院妇女儿童健康研究所,广东 广州 511400

广州市宝创生物技术有限公司,广东 广州 511400

HPV E6/E7 mRNA HPV TCT 高级别鳞状上皮内瘤变

广东省中医药局科研项目

20221043

2024

医学信息
国家卫生部信息化管理领导小组 中国电子学会中国医药信息学分会 陕西文博生物信息工程研究所

医学信息

影响因子:0.161
ISSN:1006-1959
年,卷(期):2024.37(18)